Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farb

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 25, 2004
Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosisMarc Kollum, Andrew Farb, Ralf Schreiber, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 11, 2003
Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patientGiulio Guagliumi, Renu Virmani, Giuseppe Musumeci, et al.
Circulation|January 28, 2004
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Renu Virmani, Giulio Guagliumi, Andrew Farb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2004
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem studyAllen P Burke, Frank D Kolodgie, Arthur Zieske, et al.
Circulation|August 11, 2004
Extracellular matrix changes in stented human coronary arteriesAndrew Farb, Frank D Kolodgie, Jin-Yong Hwang, et al.
Circulation|September 5, 2002
Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxelFrank D Kolodgie, Michael John, Charanjit Khurana, et al.
Radiology|September 23, 2006
Characterization of intimal changes in coronary artery specimens with MR microscopyBreno S Pessanha, Kimberlee Potter, Frank D Kolodgie, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 11, 2022
One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscapeJennifer A Rymer, Ajay J Kirtane, Andrew Farb, et al.
Journal of the American College of Cardiology|July 4, 2006
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic riskMichael Joner, Aloke V Finn, Andrew Farb, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 20, 2020
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determinationAlexandra Lansky, Tayyab Shah, William Wijns, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 25, 2004
Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosisMarc Kollum, Andrew Farb, Ralf Schreiber, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 11, 2003
Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patientGiulio Guagliumi, Renu Virmani, Giuseppe Musumeci, et al.
Circulation|January 28, 2004
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Renu Virmani, Giulio Guagliumi, Andrew Farb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2004
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem studyAllen P Burke, Frank D Kolodgie, Arthur Zieske, et al.
Circulation|August 11, 2004
Extracellular matrix changes in stented human coronary arteriesAndrew Farb, Frank D Kolodgie, Jin-Yong Hwang, et al.
Circulation|September 5, 2002
Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxelFrank D Kolodgie, Michael John, Charanjit Khurana, et al.
Radiology|September 23, 2006
Characterization of intimal changes in coronary artery specimens with MR microscopyBreno S Pessanha, Kimberlee Potter, Frank D Kolodgie, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 11, 2022
One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscapeJennifer A Rymer, Ajay J Kirtane, Andrew Farb, et al.
Journal of the American College of Cardiology|July 4, 2006
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic riskMichael Joner, Aloke V Finn, Andrew Farb, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 20, 2020
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determinationAlexandra Lansky, Tayyab Shah, William Wijns, et al.
Pageof 10